Chronimed Selected To Provide Specialty Pharmacy Services To Mutual Of Omaha Members
MINNEAPOLIS, December 15, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that it signed a contract with Mutual of Omaha for the distribution of transplant and injectable medications. This contract allows for provision of Chronimed's Specialty Pharmacy products and services to the roughly 1.3 million people currently covered by Mutual of Omaha's health insurance plans. In addition to pharmaceutical distribution, Chronimed will provide its proprietary Life Management ProgramsSM for Transplant and Injectables patients.
Under the terms of the agreement, Chronimed will be the primary national provider of these specialty pharmacy products and services. Commenting on the contract signing, Henry F. Blissenbach, Pharm.D., Chronimed's president and COO, said, "We are very pleased to enter a relationship with an established and respected managed care company such as Mutual of Omaha. We are truly excited they have embraced our Life Management concepts, and look forward to the successful management of their injectable and transplant patients."
Sandra Chong, First Vice President of Health Management Services at Mutual of Omaha, explains the value of the Chronimed relationship, "We were looking for a healthcare services company that could offer an integrated program of pharmaceutical distribution and patient monitoring. After reviewing the proposals of several different companies, we determined that Chronimed's Life Management ProgramsSM, Chronimed's focus on chronic conditions and their passion for quality customer service, combined to make them an ideal partner for us."
Chronimed Inc. is a leading integrated healthcare company specializing in specialty pharmacy services, diagnostic products, and disease management for people with chronic health conditions. The company develops, manufactures, markets and/or distributes pharmaceuticals, medical diagnostic products, and provides specialized patient management services nationwide for people with long-term chronic conditions such as organ transplants, HIV/AIDS, diabetes, and diseases treated with injectable medications. Chronimed works directly with patients, providers, and payors to improve clinical and cost-of-care outcomes.
Mutual of Omaha, headquartered in Omaha, NE, operates managed health care plans throughout the United States, serving approximately 1.3 million members.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of managed care contracts; and the risks described from time to time in the Company's SEC reports.
March 13, 2000
Contacts:
Paul S. Dunn
Investor Relations
or
Maurice R. Taylor, II
Chairman and CEO
Chronimed Inc.
(612) 979-3600